TREM2 and prostate neoplasm: By combining single-cell and spatial transcriptomics, along with flow cytometry and immunohistochemical analyses, we now reveal that prostatic tumors of such mice are hypoxic and progress within a complex immune microenvironment, including neutrophils, TREM2+ macrophages, and CCR2+ myeloid cells.